BRNHF (Broncus Holding) Short Interest


BRNHF Broncus Holding Corp BRNHF
39 GF Score
Price $0.08
! 7 Warning Signs
View Full Analysis

What is Broncus Holding Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BRNHF vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Broncus Holding's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Broncus Holding Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's Short Interest distribution charts can be found below:

* The bar in red indicates where Broncus Holding's Short Interest falls into.


BRNHF
39GF Score
Broncus Holding Corp BRNHF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Broncus Holding Business Description

Other Exchanges 02216:Hong Kong
Address No. 88 Jiangling Road, Xixing Street, Room 801, 8th Floor, Building 8, Binjiang District, Hangzhou, CHN
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
39GF Score

Get the complete analysis for BRNHF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price